logo
What is the COVID-19 situation in India?

What is the COVID-19 situation in India?

The Hindu07-06-2025

The story so far: After a rise in COVID-19 numbers in Southeast Asia, India has started to show an uptick in the number of cases over the last couple of weeks. The numbers slowly grew to hit 5,755 cases (as of Saturday 5:30 pm) as per the Ministry of Health's COVID-19 dashboard.
What is the medical advice?
The same dashboard states that 5,484 people have been discharged. Even as the numbers rise, doctors and experts have repeatedly stated that seasonal spikes and dips in COVID-19 cases are to be expected, since it had moved from a pandemic to an endemic infection. The COVID-19 virus is co-circulating with other seasonal viruses, they point out, and currently the dominant strain is an Omicron sub-variant from which the subcontinent has adequate immunity. The cases have not been severe; from the point of transmissibility too, the R0 (reproductive number) is not that worrying to indicate a high contagion factor.
What is the situation in the country today?
As of now, the variants of COVID-19 doing the rounds in India are descendants of the Omicron variant, first reported in November 2021. The emerging sub-variants, NB.1.8.1 and LF.7, driving the current COVID-19 surge are descendants of JN.1, a sub-lineage of the Omicron BA.2.86 variant. In Kerala for instance, a senior health department official said that 'almost all of the samples sent for whole genome sequencing from the State have shown that the circulating virus variant is LF.1, one of the descendants of Omicron, the immune evasiveness of which is quite well-known.' Cases have mostly been mild, according to the Indian Council of Medical Research (ICMR). The reported symptoms are those of the common cold or seasonal flu, including fever, cough, sore throat, runny nose, headache, fatigue, body aches, and loss of appetite. P. Senthur Nambi, senior consultant, Infectious Diseases, Apollo Hospitals, Chennai, said most of the COVID-19 patients he had seen so far have done well. 'Most of them had only an upper respiratory infection. These patients were managed based on their symptoms and most of them did not require any COVID specific antiviral medications. Prior exposure to the infection, the effects of the vaccines taken or a combination of both factors with vaccine-induced antibodies could be playing a protective role,' he explained. 'The key difference with these new strains,' said Sujan Bardhan, consultant (Tuberculosis and chest diseases), Narayana Hospital, R.N. Tagore Hospital, Kolkata, 'is their speed, not their severity. Hospitals are well-prepared and the healthcare system remains under no immediate strain. Nonetheless, the importance of basic preventive measures cannot be overstated.'
What is the vaccine position?
India launched the world's largest COVID-19 immunisation drive in January 2021. To date, over 220 crore doses of COVID-19 vaccines have been administered in the country as per the CoWIN dashboard. These were primarily of the two vaccines available then, AstraZeneca's Covishield and Bharat Biotech's Covaxin.
Rajiv Bahl, Director General of ICMR, has said there is absolutely no need to initiate mass booster doses for COVID-19 vaccines at present, and neither is there a direction from the Central government on this. As cases rise, Dr. Bahl noted that individual doctors could recommend booster doses to patients on a case-to-case basis.
He further explained that the need for mass vaccination, while not felt at present, could arise, with perhaps a mutation in the virus or its spread. 'For that, India already has the capacity to scale up production and provide for the general public. We have done this before and there is no need to panic,' he said. Since vaccines which were stocked and used in 2021 and 2022 have now fallen into disuse and expired, there are no stocks at present, a government official said. The official, however, added that the government could direct manufacturers to produce more stocks as and when necessary. Most States, including Kerala, Tamil Nadu, Karnataka and West Bengal, have no stocks or supplies of the vaccine at present either in the government or private sector.
Are vaccines needed at present?
Doctors across the board say that at present they see no need for a mass vaccination drive.
'By the time Omicron ran its course, almost all of our population had been exposed to the virus. Even when this antibody protection wanes, the long-term immune memory remains. This innate immunity plus the vaccine-derived immunity through good coverage of the initial two doses means that most people have strong hybrid immunity against COVID-19,' the Kerala health department official said. Previous vaccines may not be very effective against the Omicron variants but would, however, offer protection against serious forms of the disease.
Though two indigenously developed nasal vaccines specifically targeting the Omicron variant from Bharat Biotech and Indian Immunologicals, as well as another vaccine for the Omicron variant, were made available in the Indian market, the uptake was low, doctors said.
Kiran Madala, a Hyderabad-based doctor, part of an international group of genetic epidemiologists under the COVID Treatment Exchange Organisation, said the current World Health Organization guidelines recommend vaccines primarily for individuals above 70 years of age, those who are immunocompromised, and patients with multiple co-morbidities. Children, especially those aged two to six years, do not need vaccination unless they have underlying health issues or are immunosuppressed. Dr. Nambi in Chennai said some patients, those who have travel obligations, have requested the vaccines, but none are available at present. 'But I wish that there was an option of vaccination, not for the general population in large but for two subsets of patient groups in whom the infection could cause problems,' he said. One, those who have not received any COVID-19 vaccines or missed an infection, leaving them without immunity, while the second are those with co-morbidities and who are immuno-compromised.
T. Jacob John, retired professor of clinical virology at Christian Medical College, Vellore, also said that the elderly and immunocompromised people needed to be vaccinated again, irrespective of whether they were fully vaccinated (two doses and a booster) or had been exposed to the virus earlier.
State governments, however, have taken a more cautious stance: 'Whether vaccination is required or not depends on many factors,' said T. S. Selvavinayagam, T.N. Director of Public Health and Preventive Medicine. 'We need to study the epidemiology of the current cases before commenting on the requirement for vaccination now.' Kerala has said it was 'not advocating for or against COVID booster shots' because of the lack of epidemiological data that booster doses offered enhanced protection against emerging immune-evasive variants.
What next?
The Delhi High Court, earlier this week, directed the Centre to submit a thorough status report detailing its actions regarding the policy for sample collection, collection centres, and transportation of samples. The court also stressed urgency to finalise and implement Standard Operating Procedures.
As the virus continues to adapt, so must we, Dr. Bardhan pointed out. Staying informed and following trusted health sources, personal protection and hygiene measures such as hand washing, avoiding crowded places when possible or masking up, refraining from going outdoors when ill and maintaining a healthy, well-balanced lifestyle could help navigate this phase and any more to come.
Compiled by Zubeda Hamid, with inputs from C. Maya in Kerala, Serena Josephine M. in Chennai, Bindu Shajan Perappadan in Delhi, Afshan Yasmeen in Bengaluru, Shrabana Chatterjee in Kolkata and Siddharth Kumar Singh in Hyderabad.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Covid 19 resurges in the country: How THIS common symptom is key to the new variant
Covid 19 resurges in the country: How THIS common symptom is key to the new variant

Time of India

timean hour ago

  • Time of India

Covid 19 resurges in the country: How THIS common symptom is key to the new variant

The COVID-19 virus has made a comeback after a lull of a couple of years, and there has been a surge in the number of cases worldwide, including India. For now, most cases remain mild, and patients are recovering well at home, though the government has issued caution for those who are suffering from co-morbidities, including pregnant women, and elderly people. Tired of too many ads? go ad free now However, the COVID-19 virus continues to change and mutate, creating new variants that spread differently and cause different symptoms. One of the newest variants, called NB.1.8.1 or "Nimbus," has caught the attention of doctors and patients worldwide because it often causes a very painful sore throat, also called "razor blade throat." Let's dig deeper into the new symptom... History of the Nimbus variant Nimbus (NB.1.8.1) is a descendant of the Omicron variant, and was first detected in January 2025. Since then, it has spread quickly across many countries, including the United States, Canada, the United Kingdom, India, and parts of Asia. However, according to the World Health Organization (WHO) the variant remains mild as of now, and does not cause severe illness. Why Is Throat Pain So Common with Nimbus Doctors have noticed that many patients infected with Nimbus report a sore throat that feels extremely painful, to the extent that even drinking water feels difficult. Some describe it as if they are "swallowing razor blades" or "glass." This is different from the mild sore throat people experienced with earlier COVID variants. Leading doctors explain that in this symptom, the throat feels very dry and cracked, causing intense pain. This severe throat pain likely happens because the virus causes inflammation and irritation in the throat tissues, leading to pain that can exacerbate while eating and drinking. Tired of too many ads? go ad free now Other symptoms Though throat pain is the new symptom of the Nimbus variant, it usually comes with other common COVID symptoms. These include: Cough Fever Fatigue Muscle aches that feel like extreme fatigue and tiredness Nasal congestion that can last longer than usual Headaches Nausea or vomiting Changes in taste or smell These symptoms are similar to those seen with other Omicron variants as well. What should you do if you have a sore throat Not all sore throats will be caused by Covid. However, if you are experiencing other symptoms as well, along with a sore throat that feels sharp or burning, especially if it is severe enough to make swallowing difficult, you should: Get tested for COVID-19: Since throat pain is a key symptom of the Nimbus variant, testing can confirm if you have the virus. Stay isolated: To prevent spreading the virus to others, stay home and avoid close contact with people. Drink plenty of fluids: Even if it hurts, try to keep yourself hydrated to soothe your throat. Use throat lozenges or warm salt water gargles: These can help ease the pain temporarily. Seek medical help if symptoms worsen: If you have trouble breathing, persistent high fever, or severe pain, contact a healthcare provider immediately. Remember, sore throats can also be caused by a bacterial infection that can only be managed with antibiotics. However, since Covid is a virus, it does not respond to antibiotics. Hence, it is important to not self medicate, and consult a doctor. Vaccine is still your best bet The good news is that current COVID-19 vaccines, especially with updated boosters, continue to protect people from severe disease, hospitalization, and death caused by the Nimbus variant. While the variant can cause painful symptoms like sore throat, vaccinated individuals generally experience milder illness. Sources: World Health Organization, the Centers for Disease Control and Prevention

Docs face diagnosis challenge as viral attacks overlap with season change allergies in Kolkata kids
Docs face diagnosis challenge as viral attacks overlap with season change allergies in Kolkata kids

Time of India

time9 hours ago

  • Time of India

Docs face diagnosis challenge as viral attacks overlap with season change allergies in Kolkata kids

Kolkata: With the onset of the monsoon triggering a sudden dip in temperature, a range of viruses was unleashed, causing cough, cold, and fever. However, viral attacks are being overlapped by allergies, especially in children, triggering similar symptoms that have left both patients and doctors confused. While many have symptoms of a cold along with fever, some have the same symptoms without fever. The latter is an indication of an allergy attack rather than a viral one, say doctors. "Allergies trigger a similar bout of cough and cold but are usually not accompanied by fever. Viruses like rhinovirus, influenza, and Covid, which are now in circulation, also cause fever, though it could be low. Around 10% to 15% are getting an allergy attack, but overlapping symptoms are making it difficult to diagnose," said internal medicine consultant, Arindam Biswas. "Allergies lead to swellings in the respiratory tract and the nostrils, which are also prone to viral attacks. Viruses get attracted to swollen areas very quickly, which means one can lead to the other," he explained. Manipal Hospitals infectious diseases physician, Sayan Chakrabarty cautioned that even a mild cough can be a sign that the child's body is reacting to something more than a virus. Thus, he advised patients to don't self-medicate. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Brass Laxmi Ji Idol For Wealth, Peace & Happiness Luxeartisanship Shop Now Undo "A cold usually develops gradually and may come with a fever, while allergies strike suddenly, last longer, and don't cause a fever at all. During the monsoon, triggers like dust mites and mould can easily spark allergies ," said Vamsidhar Kedar, consultant paediatrician, Paediatric & Adult Allergist at Ankura Hospital for Women and Children, Hyderabad. Allergy attacks are often characterised by a series of sneezes in the morning, which doesn't recur during the rest of the day. Also, there could be body rashes, explained Chakrabarty. So, when should parents begin to worry? If your child keeps coughing without relief, sneezes mostly in the mornings, or wakes up congested day after day, it might not be just a cold, said Kedar, advising that children must not be taken to crowded places when there's a known outbreak. The infection was lasting two to three days for most children, said Fortis Hospital paediatrician Sumita Saha. "It was more severe for those below three years old. The rest are recovering quickly, though we have come across a fair number of allergy patients," she added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store